World’s largest study of HIV self-testing gets off the ground

Community test distributor, Harrison Gwaze, explaining the benefits of taking an HIV self-test in Zimbabwe. Photo © Eric Gauss / UNITAID
Roger Pebody
Published: 22 July 2016

Early data from STAR, the largest study yet of HIV self-testing, suggests that there is a strong demand for self-testing in rural Zimbabwe, the 21st International AIDS Conference (AIDS 2016) heard this week. Other studies examined whether self-testing kits can help the male partners of pregnant women to test and whether such use might sometimes be coercive.

The World Health Organization (WHO) defines HIV self-testing as “a process in which an individual who wants to know his or her HIV status collects a specimen, performs a test and interprets the result by him or herself, often in private”. By giving people the opportunity to test discreetly and conveniently, HIV self-testing may increase the uptake of HIV testing among people not reached by other HIV testing services, including people who have never taken a test.

The STAR project is is aiming to explore a range of distribution methods in order to understand their effectiveness in reaching end-users and facilitating linkage to care. The four year project aims to ‘catalyse’ the market for HIV self-testing and generate evidence on the feasibility, acceptability, scalability, costs and cost-effectiveness of different approaches.

As well as influencing WHO guidance and national policies, the project aims to help companies and policy makers understand the size of the market for HIV self-testing – this could encourage manufacturers to invest more in this area.

In the first phase of the study (2015-2017) over 730,000 HIV self-tests are being distributed across Malawi, Zambia and Zimbabwe. The second phase of the project (2017-2019) will be extended to South Africa and will provide a further two million tests through the most successful distribution models in order to demonstrate the population-level health impact of HIV self-testing.

Distribution models being examined include:

  • Open access, through retail pharmacies.
  • Semi-restricted distribution by community health workers, sex worker peer educators and voluntary medical male circumcision mobilisers.
  • More restrictive distribution by clinicians in various settings: public sector health facilities, male circumcision clinics, HIV testing sites and private healthcare providers.

The conference heard data from a pilot project using paid community volunteers in one rural area of Zimbabwe. A process of community consultation identified 79 volunteers who were trusted by their peers to go door-to-door to explain and distribute self-test kits.

Demand for the devices outstripped supply, with 8095 kits distributed in a month. The volunteers were successful in reaching both men and women, with an estimated 61% of adult men and 52% of adult women receiving test kits.

Health workers in the region sometimes express the view that self-testing will best be done under the supervision of a health worker, so as to ensure that counselling is provided and the result is accurately read. This was an option in the project but the overwhelming majority of people (85%) preferred to take the test in private.

Focus group discussions were held in the community a few weeks later. Most respondents appreciated both the offer of self-testing and the knowledgeable and helpful community volunteers. Nonetheless some people said it could be hard to turn down the offer of the tests “because you respect the volunteer and they have put a lot of effort coming to your house”.

During focus groups it became apparent that some people with previously diagnosed HIV used a self-test in order to ‘verify’ their HIV status.

In a second Zimbabwean study, outreach workers brought a mobile testing unit to both rural and peri-urban communities. Given the choice between being tested by a health worker and using a self-test kit, 70% chose self-testing.

Self-testing to support male partner testing

In African countries and elsewhere, women are generally tested during pregnancy, while their male partners rarely access HIV testing. Various strategies have been tried to encourage men to test during their partner’s pregnancy, with mixed results.

Could self-testing kits provided to women attending antenatal clinics make it easier for their partners to test? Researchers in Kenya conducted a randomised trial with three arms, with the aim being to increase men’s testing rates. The study enrolled 1410 pregnant women and their partners.

Among men who received a letter referring them to testing facilities, 28% tested. Among those who received an improved referral letter, 37% tested. However among men whose female partner had been provided with two self-test kits, 83% tested for HIV.

When women were given the self-test kits, they were counselled on appropriate ways to discuss their use with their partner. Women who had concerns about violent reactions from a partner were not given self-test kits.

Qualitative data from the study highlighted several barriers to men’s HIV testing, including pervasive HIV stigma. Work that kept men busy during clinic opening times, which may be too far away to be accessible, also discouraged men’s testing.

Moreover, men were described as being dismissive of women asking them to test:

“My husband just laughs and thinks that I am foolish.”

In terms of drivers of testing among male partners, privacy and the possibility of the couple testing together were both felt to be important.

“He may fear to go to the nearby clinic because maybe the doctor that you will get there, lives in your area or he knows you. Yes you are told that there is privacy, but how sure are you that he is not going to share with somebody else?”

“Between the two processes, at home and at the hospital, it is easier to do it at home because if both of you are given, you are both going to test yourself together.”

Coercion

One concern about HIV self-testing relates to whether it could be used coercively, with one person forcing another to test. In many countries where self-testing is being considered as a public health intervention, there are already high rates of gender-based violence – is it safe to provide self-testing kits in this context?

Researchers working on a self-testing research project in Blantyre, Malawi recorded 36 cases of gender-based violence during the study period, including two which were thought to be linked to HIV self-testing.

Some of their findings were paradoxical. Men were more likely than women to say that their partner had ‘coerced’ them into testing. Women often brought self-test kits into the household and the researchers consider their use to often be empowering for women.

One man recounted:

“When I got the kit I took two days without testing, then my wife said that I won’t eat that day if I don’t test. She went into the bedroom and poured water on my clothes. There was force, I knew that if I don’t test then there won’t be sex for me.”

Coercive testing was viewed as acceptable or beneficial in some contexts. One woman said:

“It is sometimes good… if one of you in the relationship is refusing to get tested you can doubt them. So it is good at times to force someone to get tested so that you all know your HIV status.”

People in stable relationships were more likely to be coerced to test. People who regularly experienced illness were more likely to be coerced to test by family members.

“It is necessary because they are wishing you well. People have to know how they are [HIV status] before it is too late.”

One of the objectives of the STAR research project into HIV self-testing, described at the beginning of this article, is to better understand how common coercion and other possible social harms are, following self-testing.

References

Sibanda EL et al. Community-based distribution of HIV self-test kits: results from a pilot of door-to-door distribution of HIV self-test kits in one rural Zimbabwean community. 21st International AIDS Conference, Durban, abstract LBPE041, 2016.

View the abstract on the conference website.

Napierala Mavedzenge S et al. Acceptability, feasibility, and preference for HIV self-testing in Zimbabwe. 21st International AIDS Conference, Durban, abstract WEPEC209, 2016.

View the abstract on the conference website.

Download the e-poster from the conference website.

Gichangi A et al. Provision of oral HIV self-test Kits triples uptake of HIV testing among male partners of antenatal care clients: results of a randomized trial in Kenya. 21st International AIDS Conference, Durban, abstract WEPEC218, 2016.

View the abstract on the conference website.

Download the e-poster from the conference website.

Lora W et al. Understanding coercion in the context of semi-supervised HIV self-testing in urban Blantyre, Malawi. 21st International AIDS Conference, Durban, abstract WEPED293, 2016.

View the abstract on the conference website.



Related news selected from other sources

More editors' picks on promoting HIV testing >

NAM’s news coverage of the International AIDS Conference has been made possible thanks to support from Merck & Co. NAM's wider conference news reporting services have been supported by Gilead, Janssen and ViiV Healthcare.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.